Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study

AJM. Meijer, FA. Diepstraten, T. Langer, L. Broer, IK. Domingo, E. Clemens, AG. Uitterlinden, ACH. de Vries, M. van Grotel, WP. Vermeij, RA. Ozinga, H. Binder, J. Byrne, E. van Dulmen-den Broeder, ML. Garrè, D. Grabow, P. Kaatsch, M. Kaiser, L....

. 2021 ; 5 (1) : 64. [pub] 20210714

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc21024383

In children with cancer, the heterogeneity in ototoxicity occurrence after similar treatment suggests a role for genetic susceptibility. Using a genome-wide association study (GWAS) approach, we identified a genetic variant in TCERG1L (rs893507) to be associated with hearing loss in 390 non-cranial irradiated, cisplatin-treated children with cancer. These results were replicated in two independent, similarly treated cohorts (n = 192 and 188, respectively) (combined cohort: P = 5.3 × 10-10, OR 3.11, 95% CI 2.2-4.5). Modulating TCERG1L expression in cultured human cells revealed significantly altered cellular responses to cisplatin-induced cytokine secretion and toxicity. These results contribute to insights into the genetic and pathophysiological basis of cisplatin-induced ototoxicity.

Audiology and Speech Pathology Department BC Children's Hospital Vancouver BC Canada

BC Children's Hospital Research Institute Vancouver BC Canada

Boyne Research Institute Drogheda Ireland

Childhood Cancer Research Group Danish Cancer Society Research Center Copenhagen Denmark

Departement of Otorhinolaryngology Erasmus Medical Center Rotterdam The Netherlands

Department of Children Hemato Oncology Motol University Hospital Prague Prague Czech Republic

Department of Clinical Medicine Faculty of Health Aarhus University and University Hospital Aarhus Denmark

Department of Internal Medicine Erasmus Medical Center Rotterdam The Netherlands

Department of Internal Medicine University Hospital of Schleswig Holstein Campus Lübeck Lübeck Germany

Department of Medical Genetics University of Alberta Edmonton AB Canada

Department of Medical Microbiology and Immunology University of Alberta Edmonton AB Canada

Department of Neurooncology IRCCS Istituto Giannina Gaslini Genova Italy

Department of Obstetrics and Gynecology Erasmus MC Sophia Children's Hospital Rotterdam The Netherlands

Department of Otorhinolaryngology Head and Neck Surgery University Hospital Utrecht Utrecht The Netherlands

Department of Pediatric and Adolescent Medicine Medical University of Graz Graz Austria

Department of Pediatric Oncology Academic Medical Center Amsterdam Amsterdam The Netherlands

Department of Pediatric Oncology and Hematology University Hospital for Children and Adolescents Lübeck Germany

Department of Pediatric Oncology Erasmus MC Sophia Children's Hospital Rotterdam The Netherlands

Department of Pediatric Oncology Hematology Immunology Stuttgart Cancer Center Olgahospital Stuttgart Germany

Department of Pediatric Oncology University of Groningen University Medical Center Groningen Groningen The Netherlands

Department of Pediatrics Aarhus University Hospital Aarhus Denmark

Department of Pediatrics and Adolescent Medicine Copenhagen University Hospital Rigshospitalet Copenhagen Denmark

Department of Phoniatrics and Pedaudiology University Hospital Münster Westphalian Wilhelm University Münster Germany

Division of Translational Therapeutics Department of Pediatrics University of British Columbia Vancouver BC Canada

Epidemiology and Biostatistics Unit and DOPO Clinic IRCCS Istituto Giannina Gaslini Genova Italy

Faculty of Pharmaceutical Sciences University of British Columbia British Columbia Canada

German Childhood Cancer Registry Institute of Medical Biostatistics Epidemiology and Informatics University Medical Center of the Johannes Gutenberg University Mainz Mainz Germany

Institute of Clinical Pharmacology Brandenburg Medical School Rüdersdorf Germany

Institute of Medical Biometry and Statistics Faculty of Medicine and Medical Center University of Freiburg Freiburg Germany

Institute of Social and Preventive Medicine University of Bern Bern Switzerland

Institute of Social Medicine and Epidemiology University of Lübeck Lübeck Germany

International Clinical Research Center Brno Czech Republic

Oncode Institute Utrecht The Netherlands

Pediatric Hematology and Oncology University Children's Hospital Bern University of Bern Bern Switzerland

Pediatric Hematology and Oncology University Children's Hospital Muenster Muenster Germany

Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands

University Hospital Brno Brno Czech Republic

VU Medical Center Amsterdam The Netherlands

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21024383
003      
CZ-PrNML
005      
20240219152407.0
007      
ta
008      
211006s2021 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s41698-021-00178-z $2 doi
035    __
$a (PubMed)34262104
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Meijer, A J M $u Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands. a.j.m.meijer-16@prinsesmaximacentrum.nl
245    10
$a TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study / $c AJM. Meijer, FA. Diepstraten, T. Langer, L. Broer, IK. Domingo, E. Clemens, AG. Uitterlinden, ACH. de Vries, M. van Grotel, WP. Vermeij, RA. Ozinga, H. Binder, J. Byrne, E. van Dulmen-den Broeder, ML. Garrè, D. Grabow, P. Kaatsch, M. Kaiser, L. Kenborg, JF. Winther, C. Rechnitzer, H. Hasle, T. Kepak, K. Kepakova, WJE. Tissing, ALF. van der Kooi, LCM. Kremer, J. Kruseova, SMF. Pluijm, CE. Kuehni, HJH. van der Pal, R. Parfitt, C. Spix, A. Tillmanns, D. Deuster, P. Matulat, G. Calaminus, AE. Hoetink, S. Elsner, J. Gebauer, R. Haupt, H. Lackner, C. Blattmann, SJCMM. Neggers, SR. Rassekh, GEB. Wright, B. Brooks, AP. Nagtegaal, BI. Drögemöller, CJD. Ross, AP. Bhavsar, AG. Am Zehnhoff-Dinnesen, BC. Carleton, O. Zolk, MM. van den Heuvel-Eibrink, PanCareLIFE Consortium, and the CPNDS Consortium
520    9_
$a In children with cancer, the heterogeneity in ototoxicity occurrence after similar treatment suggests a role for genetic susceptibility. Using a genome-wide association study (GWAS) approach, we identified a genetic variant in TCERG1L (rs893507) to be associated with hearing loss in 390 non-cranial irradiated, cisplatin-treated children with cancer. These results were replicated in two independent, similarly treated cohorts (n = 192 and 188, respectively) (combined cohort: P = 5.3 × 10-10, OR 3.11, 95% CI 2.2-4.5). Modulating TCERG1L expression in cultured human cells revealed significantly altered cellular responses to cisplatin-induced cytokine secretion and toxicity. These results contribute to insights into the genetic and pathophysiological basis of cisplatin-induced ototoxicity.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Diepstraten, F A $u Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
700    1_
$a Langer, T $u Department of Pediatric Oncology and Hematology, University Hospital for Children and Adolescents, Lübeck, Germany
700    1_
$a Broer, L $u Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands
700    1_
$a Domingo, I K $u Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, AB, Canada
700    1_
$a Clemens, E $u Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands $u Department of Pediatric Oncology, Erasmus MC - Sophia Children's Hospital, Rotterdam, The Netherlands
700    1_
$a Uitterlinden, A G $u Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands
700    1_
$a de Vries, A C H $u Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands $u Department of Pediatric Oncology, Erasmus MC - Sophia Children's Hospital, Rotterdam, The Netherlands
700    1_
$a van Grotel, M $u Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
700    1_
$a Vermeij, W P $u Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands $u Oncode Institute, Utrecht, The Netherlands
700    1_
$a Ozinga, R A $u Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands $u Oncode Institute, Utrecht, The Netherlands
700    1_
$a Binder, H $u German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany $u Institute of Medical Biometry and Statistics, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany
700    1_
$a Byrne, J $u Boyne Research Institute, Drogheda, Ireland
700    1_
$a van Dulmen-den Broeder, E $u Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands $u VU Medical Center, Amsterdam, The Netherlands
700    1_
$a Garrè, M L $u Department of Neurooncology, IRCCS Istituto Giannina Gaslini, Genova, Italy
700    1_
$a Grabow, D $u German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany
700    1_
$a Kaatsch, P $u German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany
700    1_
$a Kaiser, M $u German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany
700    1_
$a Kenborg, L $u Childhood Cancer Research Group, Danish Cancer Society Research Center, Copenhagen, Denmark
700    1_
$a Winther, J F $u Childhood Cancer Research Group, Danish Cancer Society Research Center, Copenhagen, Denmark $u Department of Clinical Medicine, Faculty of Health, Aarhus University and University Hospital, Aarhus, Denmark
700    1_
$a Rechnitzer, C $u Department of Pediatrics and Adolescent Medicine, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark
700    1_
$a Hasle, H $u Department of Pediatrics, Aarhus University Hospital, Aarhus, Denmark
700    1_
$a Kepák, Tomáš, $u University Hospital Brno, Brno, Czech Republic $u International Clinical Research Center (FNUSA-ICRC), Brno, Czech Republic $d 1972- $7 xx0081397
700    1_
$a Kepáková, Kateřina, $u University Hospital Brno, Brno, Czech Republic $u International Clinical Research Center (FNUSA-ICRC), Brno, Czech Republic $d 1972- $7 mzk2004246514
700    1_
$a Tissing, W J E $u Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands $u Department of Pediatric Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
700    1_
$a van der Kooi, A L F $u Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands $u Department of Obstetrics and Gynecology, Erasmus MC - Sophia Children's Hospital, Rotterdam, The Netherlands
700    1_
$a Kremer, L C M $u Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands $u Department of Pediatric Oncology, Academic Medical Center Amsterdam, Amsterdam, The Netherlands
700    1_
$a Kruseova, J $u Department of Children Hemato-Oncology, Motol University Hospital Prague, Prague, Czech Republic
700    1_
$a Pluijm, S M F $u Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
700    1_
$a Kuehni, C E $u Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland $u Pediatric Hematology and Oncology, University Children's Hospital Bern, University of Bern, Bern, Switzerland
700    1_
$a van der Pal, H J H $u Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands $u Department of Pediatric Oncology, Academic Medical Center Amsterdam, Amsterdam, The Netherlands
700    1_
$a Parfitt, R $u Department of Phoniatrics and Pedaudiology, University Hospital Münster, Westphalian Wilhelm University, Münster, Germany
700    1_
$a Spix, C $u German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany
700    1_
$a Tillmanns, A $u Department of Phoniatrics and Pedaudiology, University Hospital Münster, Westphalian Wilhelm University, Münster, Germany
700    1_
$a Deuster, D $u Department of Phoniatrics and Pedaudiology, University Hospital Münster, Westphalian Wilhelm University, Münster, Germany
700    1_
$a Matulat, P $u Department of Phoniatrics and Pedaudiology, University Hospital Münster, Westphalian Wilhelm University, Münster, Germany
700    1_
$a Calaminus, G $u Pediatric Hematology and Oncology, University Children's Hospital Muenster, Muenster, Germany
700    1_
$a Hoetink, A E $u Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Utrecht, Utrecht, The Netherlands
700    1_
$a Elsner, S $u Institute of Social Medicine and Epidemiology, University of Lübeck, Lübeck, Germany
700    1_
$a Gebauer, J $u Department of Internal Medicine, University Hospital of Schleswig-Holstein, Campus Lübeck, Lübeck, Germany
700    1_
$a Haupt, R $u Epidemiology and Biostatistics Unit and DOPO Clinic, IRCCS Istituto Giannina Gaslini, Genova, Italy
700    1_
$a Lackner, H $u Department of Pediatric and Adolescent Medicine, Medical University of Graz, Graz, Austria
700    1_
$a Blattmann, C $u Department of Pediatric Oncology/Hematology/Immunology, Stuttgart Cancer Center, Olgahospital, Stuttgart, Germany
700    1_
$a Neggers, S J C M M $u Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands $u Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands
700    1_
$a Rassekh, S R $u BC Children's Hospital Research Institute, Vancouver, BC, Canada $u Division of Translational Therapeutics, Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada
700    1_
$a Wright, G E B $u BC Children's Hospital Research Institute, Vancouver, BC, Canada $u Division of Translational Therapeutics, Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada
700    1_
$a Brooks, B $u Audiology and Speech Pathology Department, BC Children's Hospital, Vancouver, BC, Canada
700    1_
$a Nagtegaal, A P $u Departement of Otorhinolaryngology, Erasmus Medical Center, Rotterdam, The Netherlands
700    1_
$a Drögemöller, B I $u BC Children's Hospital Research Institute, Vancouver, BC, Canada $u Faculty of Pharmaceutical Sciences, University of British Columbia, British Columbia, Canada
700    1_
$a Ross, C J D $u BC Children's Hospital Research Institute, Vancouver, BC, Canada $u Faculty of Pharmaceutical Sciences, University of British Columbia, British Columbia, Canada
700    1_
$a Bhavsar, A P $u Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, AB, Canada $u Department of Medical Genetics, University of Alberta, Edmonton, AB, Canada
700    1_
$a Am Zehnhoff-Dinnesen, A G $u Department of Phoniatrics and Pedaudiology, University Hospital Münster, Westphalian Wilhelm University, Münster, Germany
700    1_
$a Carleton, B C $u BC Children's Hospital Research Institute, Vancouver, BC, Canada $u Faculty of Pharmaceutical Sciences, University of British Columbia, British Columbia, Canada
700    1_
$a Zolk, O $u Institute of Clinical Pharmacology, Brandenburg Medical School, Rüdersdorf, Germany
700    1_
$a van den Heuvel-Eibrink, M M $u Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands $u Department of Pediatric Oncology, Erasmus MC - Sophia Children's Hospital, Rotterdam, The Netherlands
710    2_
$a PanCareLIFE Consortium
710    2_
$a and the CPNDS Consortium
773    0_
$w MED00207110 $t NPJ precision oncology $x 2397-768X $g Roč. 5, č. 1 (2021), s. 64
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34262104 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20211006 $b ABA008
991    __
$a 20240219152406 $b ABA008
999    __
$a ind $b bmc $g 1708299 $s 1144880
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 5 $c 1 $d 64 $e 20210714 $i 2397-768X $m NPJ precision oncology $n NPJ Precis Oncol $x MED00207110
LZP    __
$a Pubmed-20211006

Najít záznam

Citační ukazatele

Možnosti archivace